Impaired fetal thymic growth precedes clinical preeclampsia: A case-control study

Journal of Reproductive Immunology

Volumn 94, Issue 2, 2012, Pages 183-189

  Eviston, David P ^a   Quinton, Ann E ^a   Benzie, Ron J ^a   Peek, Michael J ^a   Martin, Andrew ^b   Nanan, Ralph K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Fetus; Gestation; Preeclampsia; Thymus; Ultrasound

Indexed keywords

STEROID;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; FETUS; FETUS GROWTH; GESTATIONAL AGE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NULLIPARA; ORGAN GROWTH; ORGAN SIZE; PREECLAMPSIA; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SPINE; STERNUM; THYMUS; ULTRASOUND;

ADAPTIVE IMMUNITY; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; ORGAN SIZE; PRE-ECLAMPSIA; PREGNANCY; PREVALENCE; PROGNOSIS; THYMUS GLAND;

EID: 84861194226     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.04.001     Document Type: Article

References (25)

1. Benediktsson R., Calder A.A., Edwards C.R., Seckl J.R. Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin. Endocrinol. (Oxf.) 1997, 46:161-166.
2. Brown M.A., Lindheimer M.D., De Swiet M., Van Assche A., Moutquin J.M. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens. Pregnancy 2001, 20:IX-XIV.
3. Caffey J., Silbey R. Regrowth and overgrowth of the thymus after atrophy induced by the oral administration of adrenocorticosteroids to human infants. Pediatrics 1960, 26:762-770.
4. Causevic M., Mohaupt M. 11beta-hydroxysteroid dehydrogenase type 2 in pregnancy and preeclampsia. Mol. Aspects Med. 2007, 28:220-226.
5. Cho J.Y., Min J.Y., Lee Y.H., Mccrindle B., Hornberger L.K., Yoo S.J. Diameter of the normal fetal thymus on ultrasound. Ultrasound Obstet. Gynecol. 2007, 29:634-638.
6. De Leon-Luis J., Ruiz Y., Gamez F., Pintado P., Oyelese Y., Pereda A., et al. Comparison of measurements of the transverse diameter and perimeter of the fetal thymus obtained by magnetic resonance and ultrasound imaging. J. Magn. Reson. Imaging 2011, 33:1100-1105.
7. Di Naro E., Cromi A., Ghezzi F., Raio L., Uccella S., D'addario V., et al. Fetal thymic involution: a sonographic marker of the fetal inflammatory response syndrome. Am. J. Obstet. Gynecol. 2006, 194:153-159.
8. Duley L. The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 2009, 33:130-137.
9. Hale L.P., Braun R.D., Gwinn W.M., Greer P.K., Dewhirst M.W. Hypoxia in the thymus: role of oxygen tension in thymocyte survival. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H1467-H1477.
10. Hardy D.B., Yang K. The expression of 11 beta-hydroxysteroid dehydrogenase type 2 is induced during trophoblast differentiation: effects of hypoxia. J. Clin. Endocrinol. Metab. 2002, 87:3696-3701.
11. Hasselbalch H., Nielsen M.B., Jeppesen D., Pedersen J.F., Karkov J. Sonographic measurement of the thymus in infants. Eur. Radiol. 1996, 6:700-703.
12. Kopelman J.J., Levitz M. Plasma cortisol levels and cortisol binding in normal and pre-eclamptic pregnancies. Am. J. Obstet. Gynecol. 1970, 108:925-930.
13. Ma D.D., Ho A.H., Hoffbrand A.V. Effect of thymosin on glucocorticoid receptor activity and glucocorticoid sensitivity of human thymocytes. Clin. Exp. Immunol. 1984, 55:273-280.
14. Matthiesen L., Berg G., Ernerudh J., Ekerfelt C., Jonsson Y., Sharma S. Immunology of preeclampsia. Chem. Immunol. Allergy 2005, 89:49-61.
15. Mccalla C.O., Nacharaju V.L., Muneyyirci-Delale O., Glasgow S., Feldman J.G. Placental 11 beta-hydroxysteroid dehydrogenase activity in normotensive and pre-eclamptic pregnancies. Steroids 1998, 63:511-515.
16. Mohamed N., Eviston D.P., Quinton A.E., Benzie R.J., Kirby A.C., Peek M.J., et al. Smaller fetal thymuses in pre-eclampsia: a prospective cross-sectional study. Ultrasound Obstet. Gynecol. 2011, 37:410-415.
17. Parent G., Chevalier P., Zalles L., Sevilla R., Bustos M., Dhenin J.M., et al. In vitro lymphocyte-differentiating effects of thymulin (Zn-FTS) on lymphocyte subpopulations of severely malnourished children. Am. J. Clin. Nutr. 1994, 60:274-278.
18. Saito S., Shiozaki A., Nakashima A., Sakai M., Sasaki Y. The role of the immune system in preeclampsia. Mol. Aspects Med. 2007, 28:192-209.
19. Santner-Nanan B., Peek M.J., Khanam R., Richarts L., Zhu E., Fazekas De St Groth B., et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J. Immunol. 2009, 183:7023-7030.
20. Schoof E., Girstl M., Frobenius W., Kirschbaum M., Dorr H.G., Rascher W., et al. Decreased gene expression of 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia. J. Clin. Endocrinol. Metab. 2001, 86:1313-1317.
21. Steegers E.A., Von Dadelszen P., Duvekot J.J., Pijnenborg R. Pre-eclampsia. Lancet 2010, 376:631-644.
22. Toti P., De Felice C., Stumpo M., Schurfeld K., Di Leo L., Vatti R., et al. Acute thymic involution in fetuses and neonates with chorioamnionitis. Hum. Pathol. 2000, 31:1121-1128.
23. Yang K. Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids. Rev. Reprod. 1997, 2:129-132.
24. Yoo S.J., Lee Y.H., Kim E.S., Ryu H.M., Kim M.Y., Choi H.K., et al. Three-vessel view of the fetal upper mediastinum: an easy means of detecting abnormalities of the ventricular outflow tracts and great arteries during obstetric screening. Ultrasound Obstet. Gynecol. 1997, 9:173-182.
25. Zalel Y., Gamzu R., Mashiach S., Achiron R. The development of the fetal thymus: an in utero sonographic evaluation. Prenat. Diagn. 2002, 22:114-117.